Prosopis farcta: Potent Antifungal Activity Against Trichophyton mentagrophytes Strains; A Research Based on an Ethnobotanical Study

Salimi-Sabour, Ebrahim; Fattahi, Mahsa; Rezaei, Kamran; Lotfali, Ensieh; Khademian, Azadeh

doi:10.30699/ijmm.16.2.127

year 16, Issue 2 (March - April 2022) Iran J Med Microbiol 2022, 16(2): 127-133 | Back to browse issues page

‎ 10.30699/ijmm.16.2.127

Mendeley

Zotero

RefWorks

Salimi-Sabour E, Fattahi M, Rezaei K, Lotfali E, Khademian A. Prosopis farcta: Potent Antifungal Activity Against Trichophyton mentagrophytes Strains; A Research Based on an Ethnobotanical Study. Iran J Med Microbiol 2022; 16 (2) :127-133
URL: http://ijmm.ir/article-1-1426-en.html

Prosopis farcta: Potent Antifungal Activity Against Trichophyton mentagrophytes Strains; A Research Based on an Ethnobotanical Study

Ebrahim Salimi-Sabour¹

, Mahsa Fattahi²

, Kamran Rezaei³

, Ensieh Lotfali

⁴, Azadeh Khademian⁵

1- Department of Pharmacognosy and Traditional Pharmacy, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
3- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran , ensiehlotfali@yahoo.com
5- Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran

Abstract: (1601 Views)

Background and Objective: Dermatophytosis is a superficial fungal disease. Prosopis farcta has attracted attention for ethnobotany and medical purposes. The present study aimed to investigate the antifungal properties of Prosopis farcta extracts against Trichophyton mentagrophytes (PTCC 5054) and five archived terbinafine resistant clinical isolates of T. mentagrophyte, based on an ethnobotanical report in Yazd province (Iran).
Materials and Methods: In vitro drug susceptibility for methanol extract and amphotericin B was carried out according to the CLSI-M38-A2. A topical solution (1%) was formulated by root extract of P. farcta. The nine male Sprague rats were infected by T. mentagrophytes and assessed for in vivo anti-dermatophytic activity.
Results: The MIC value of amphotericin B was ≤ 0.5 μg/mL against all strains. The methanol extract showed the lowest MIC and MFC values on fungal activity (both with 0.00625 mg/mL). The complete cure of 21-day period with terbinafine is reduced to 10 days with methanol 80% root extract of P. farcta solution.
Conclusion: Compared with amphotericin B, P. farcta could be considered a potential antifungal agent in terbinafine-resistant clinical isolates of dermatophytes.

Keywords: Dermatophytes, Ethnobotanical Report, Prosopis farcta, Terbinafine Resistant, Trichophyton mentagrophytes

Full-Text [PDF 789 kb] (726 Downloads) | | Full-Text (HTML) (957 Views)

Type of Study: Original Research Article | Subject: Medical Mycology
Received: 2021/08/11 | Accepted: 2021/12/29 | ePublished: 2022/02/10

References

1. Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, van de Veerdonk FL, et al. Immunotherapeutic approaches to treatment of fungal diseases. Lancet Infect Dis. 2017;17(12):e393-e402. [DOI:10.1016/S1473-3099(17)30442-5]

2. Ghajari A, Lotfali E, Norouzi M, Arab-Mazar Z. First report of Vulvovaginitis due to Cryptococcus magnus in Iran. Curr Med Mycol. 2018;4(1):30. [DOI:10.18502/cmm.4.1.32] [PMID] [PMCID]

3. Nenoff P, Krüger C, Ginter‐Hanselmayer G, Tietz HJ. Mycology-an update. Part 1: Dermatomycoses: causative agents, epidemiology and pathogenesis. JDDG. 2014;12(3):188-210. [DOI:10.1111/ddg.12245] [PMID]

4. Darkes MJ, Scott LJ, Goa KL. Terbinafine. Am J Clin Dermatol. 2003;4(1):39-65. [DOI:10.2165/00128071-200304010-00005] [PMID]

5. Badali H, Mohammadi R, Mashedi O, de Hoog GS, Meis JF. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses. 2015;58(5):303-7. [DOI:10.1111/myc.12315] [PMID]

6. Fattahi A, Shirvani F, Ayatollahi A, Rezaei‐Matehkolaei A, Badali H, Lotfali E, et al. Multidrug‐resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature. Int J Dermatol. 2021;60(6):686-92. [DOI:10.1111/ijd.15226] [PMID]

7. Firooz A, Lotfali E, Fattahi M, Fattahi M, Miramin Mohammadi A, Shahrzad Kavkani M. A Case of Terbinafine-Resistant Tinea Cruris Caused by Trichophyton tonsurans. Case Rep Dermatol Med. 2021;2021:9611072. [DOI:10.1155/2021/9611072] [PMID] [PMCID]

8. Quiroga EN, Sampietro AR, Vattuone MA. Screening antifungal activities of selected medicinal plants. J Ethnopharmacol. 2001;74(1):89-96. [DOI:10.1016/S0378-8741(00)00350-0]

9. Jahromi MAF, Etemadfard H, Zebarjad Z. Antimicrobial and antioxidant characteristics of volatile components and ethanolic fruit extract of Prosopis farcta (Bank & Soland.). Trends Pharma Sci. 2018;4(3):177-86.

10. Salari S, Bahabadi SE, Samzadeh-Kermani A, Yosefzaei F. In-vitro evaluation of antioxidant and antibacterial potential of greensynthesized silver nanoparticles using Prosopis farcta fruit extract. Iran J Pharma Res. 2019;18(1):430.

11. Omidi A, Ghazaghi M. Prosopis farcta beans increase HDL cholesterol and decrease LDL cholesterol in ostriches (Struthio camelus). Trop Anim Health Prod. 2013;45(2):431-4. [DOI:10.1007/s11250-012-0234-x] [PMID]

12. Sharifi-Rad J, Hoseini-Alfatemi S, Sharifi-Rad M, Miri A. Phytochemical screening and antibacterial activity of different parts of the Prosopis farcta extracts against methicillin-resistant Staphylococcus aureus (MRSA). Minerva Biotecnol. 2014;26(4):287-93.

13. Al-Aboudi A, Afifi FU. Plants used for the treatment of diabetes in Jordan: a review of scientific evidence. Pharmal Biol. 2011;49(3):221-39. [DOI:10.3109/13880209.2010.501802] [PMID]

14. Al-Ameri AK. Evaluation of antimicrobial activity of aqueous extract ofProsopis farcta pods. Tikret J Pharma Sci. 2006;2(2):78-84.

15. Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S. 2008;3:6-12.

16. Hay RJ, Calderon RA, Collins MJ. Experimental dermatophytosis: the clinical and histopathologic features of a mouse model using Trichophyton quinckeanum (mouse favus). J Invest Dermatol. 1983;81(3):270-4. [DOI:10.1111/1523-1747.ep12518292] [PMID]

17. Akroum S. Antifungal activity of camellia sinensis crude extracts against four species of candida and microsporum persicolor. Journal de mycologie medicale. 2018;28(3):424-7. [DOI:10.1016/j.mycmed.2018.06.003] [PMID]

18. Odds F, Ausma J, Van Gerven F, Woestenborghs F, Meerpoel L, Heeres J, et al. In vitro and in vivo activities of the novel azole antifungal agent R126638. Antimicrobial agents and chemotherapy. 2004;48(2):388-91. [DOI:10.1128/AAC.48.2.388-391.2004] [PMID] [PMCID]

19. Ahmad Nasrollahi S, Fattahi A, Naeimifar A, Lotfali E, Firooz A, Khamesipoor A, et al. The in vitro effect of nanoliposomal amphotericin B against two clinically important dermatophytes. Int J Dermatol. 2021. [DOI:10.1111/ijd.15609] [PMID]

20. Marquez L, Quave CL. Prevalence and therapeutic challenges of fungal drug resistance: role for plants in drug discovery. Antibiotics. 2020;9(4):150. [DOI:10.3390/antibiotics9040150] [PMID] [PMCID]

21. Ali‐Shtayeh M, Abu Ghdeib SI. Antifungal activity of plant extracts against dermatophytes. Mycoses. 1999;42(11‐12):665-72. [DOI:10.1046/j.1439-0507.1999.00499.x] [PMID]

22. Toreyhi H, Lotfali E, Fattahi A, Rezaee Y, Ghasemi R, Salimi-Sabour E. A Review on Anti Dermatophytosis Potential of Medicinal Plants: In-Vitro, In-Vivo and Important Components. Novelty Biomed.

23. Salimi-Sabour E, H Shirazi F, Mahboubi A, Mojab F, Irani M. Biological Activities and the Essential Oil Analysis of Cousinia harazensis and C. calocephala. Iranian Journal of Pharmaceutical Research. 2021;20(3):140-50.

24. Malheiros A, Cechinel Filho V, Schmitt CB, Yunes RA, Escalante A, Svetaz L, et al. Antifungal activity of drimane sesquiterpenes from Drimys brasiliensis using bioassay-guided fractionation. J Pharmal Sci. 2005;8(2):335-9.

25. Mishra AP, Sharifi-Rad M, Shariati MA, Mabkhot YN, Al-Showiman SS, Rauf A, et al. Bioactive compounds and health benefits of edible Rumex species-A review. Cell Mol Biol. 2018;64(8):27-34. [DOI:10.14715/cmb/2018.64.8.5]

26. Hsieh A, Quenan S, Riat A, Toutous-Trellu L, Fontao L. A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis. J Mycol Med. 2019;29(4):352-5. [DOI:10.1016/j.mycmed.2019.100903] [PMID]

27. Taghipour S, Shamsizadeh F, Pchelin IM, Rezaei-Matehhkolaei A, Mahmoudabadi AZ, Valadan R, et al. Emergence of terbinafine resistant Trichophyton mentagrophytes in Iran, harboring mutations in the squalene epoxidase (SQLE) gene. Infection and Drug Resistance. 2020;13:845. [DOI:10.2147/IDR.S246025] [PMID] [PMCID]

28. Burmester A, Hipler U, Uhrlaß S, Nenoff P, Singal A, Verma S, et al. Indian T. mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance. Mycoses. 2020. [DOI:10.1111/myc.13150] [PMID]

29. Saad AM, Ghareeb MA, Abdel-Aziz MS, Madkour HMF, Khalaf OM, El-Ziaty AK, et al. Chemical constituents and biological activities of different solvent extracts of Prosopis farcta growing in Egypt. J Pharma Phytother. 2017;9(5):67-76. [DOI:10.5897/JPP2017.0452]

30. Noroozi R, Sadeghi E, Yousefi H, Taheri M, Sarabi P, Dowati A, et al. Wound healing features of Prosopis farcta: in vitro evaluation of antibacterial, antioxidant, proliferative and angiogenic properties. Gene Rep. 2019;17:100482. [DOI:10.1016/j.genrep.2019.100482]

31. Maoz M, Neeman I. Antimicrobial effects of aqueous plant extracts on the fungi Microsporum canis and Trichophyton rubrum and on three bacterial species. Lett Appl Microbiol. 1998;26(1):61-3. [DOI:10.1046/j.1472-765X.1998.00277.x] [PMID]

32. Balakumar S, Rajan S, Thirunalasundari T, Jeeva S. Antifungal activity of Ocimum sanctum Linn.(Lamiaceae) on clinically isolated dermatophytic fungi. Asian Pac J Trop Med. 2011;4(8):654-7. [DOI:10.1016/S1995-7645(11)60166-1]

33. Mugnaini L, Nardoni S, Pistelli L, Leonardi M, Giuliotti L, Benvenuti MN, et al. A herbal antifungal formulation of Thymus serpillum, Origanum vulgare and Rosmarinus officinalis for treating ovine dermatophytosis due to Trichophyton mentagrophytes. Mycoses. 2013;56(3):333-7. [DOI:10.1111/myc.12034] [PMID]

34. Inouye S, Uchida K, Abe S. Volatile composition and vapour activity against Trichophyton mentagrophytes of 36 aromatic herbs cultivated in Chichibu district in Japan. Int J Aromather. 2006;16(3-4):159-68. [DOI:10.1016/j.ijat.2006.09.001]

35. Ahn D-J, Kwak Y-S, Kim M-J, Lee J-C, Shin C-S, Jeong K-T. Screening of herbal plant extracts showing antimicrobial activity against some food spoilage and pathogenic microorganisms. Korean J Med Crop Sci. 2000;8(2):109-16.